NANOG+ cells exhibited stem-like, metastatic, anti-apoptotic properties, and resistance to multi-modal therapies, such as chemo-, radio-, and immunotherapy, by hyperactivation of the EGFR-AKT pathway, indicating the important role of NANOG signaling in these refractory phenotypes of tumor cells21–27. The gene discussed is AKT1; the disease is neoplasm.